UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 133

Sortiert nach

Ineffective Erythropoiesis in β-Thalassaemia: Key Steps and Therapeutic Options by Drugs

International journal of molecular sciences, 2021-07, Vol.22 (13), p.7229

2021

Link zum Volltext

Verfügbarkeit prüfen

Pharmacological and clinical evaluation of deferasirox formulations for treatment tailoring

Scientific reports, 2021-06, Vol.11 (1), p.12581-12581, Article 12581

2021

Link zum Volltext

Verfügbarkeit prüfen

Does Hepcidin Tuning Have a Role among Emerging Treatments for Thalassemia?

Journal of clinical medicine, 2022-08, Vol.11 (17), p.5119

2022

Link zum Volltext

Verfügbarkeit prüfen

Epigenetic therapy for Friedreich ataxia

Annals of neurology, 2014-10, Vol.76 (4), p.489-508

2014

Link zum Volltext

Verfügbarkeit prüfen

Bone densitometry in Thalassemia major: a closer look at pitfalls and operator-related errors in a 10-year follow-up population

Radiologia medica, 2024-03, Vol.129 (3), p.488-496

2024

Link zum Volltext

Verfügbarkeit prüfen

Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver

Hepatology (Baltimore, Md.), 2004-01, Vol.39 (1), p.179-187

2004

Link zum Volltext

Verfügbarkeit prüfen

Fontan circulation causes early, severe liver damage. Should we offer patients a tailored strategy?

International journal of cardiology, 2016-04, Vol.209, p.60-65

2016

Link zum Volltext

Verfügbarkeit prüfen

Treating Thalassemia Patients with Luspatercept: An Expert Opinion Based on Current Evidence

Journal of clinical medicine, 2023-03, Vol.12 (7), p.2584

2023

Link zum Volltext

Verfügbarkeit prüfen

Pregnancy and β-thalassemia: an Italian multicenter experience

Haematologica (Roma), 2010-03, Vol.95 (3), p.376-381

2010

Link zum Volltext

Verfügbarkeit prüfen

Prevalence and prognostic impact of left ventricular non-compaction in patients with thalassemia

Internal and emergency medicine, 2019-11, Vol.14 (8), p.1299-1306

2019

Link zum Volltext

Verfügbarkeit prüfen

The effect of vitamin D pathway genes and deferasirox pharmacogenetics on liver iron in thalassaemia major patients

The pharmacogenomics journal, 2019-10, Vol.19 (5), p.417-427

2019

Link zum Volltext

Verfügbarkeit prüfen

The Influence of Cardiovascular Risk Factors and Hypogonadism on Cardiac Outcomes in an Aging Population of Beta-Thalassemia Patients

Journal of cardiovascular development and disease, 2021-12, Vol.9 (1), p.3

2021

Link zum Volltext

Verfügbarkeit prüfen

Long-term safety and erythroid response with luspatercept treatment in patients with β-thalassemia

Therapeutic advances in hematology, 2022-01, Vol.13, p.20406207221134404-20406207221134404

2022

Link zum Volltext

Verfügbarkeit prüfen

Non-Vitamin K Antagonist Oral Anticoagulants in Patients with β-Thalassemia

Biology (Basel, Switzerland), 2023-03, Vol.12 (4), p.491

2023

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Role of Multiparametric Cardiac Magnetic Resonance in Neo Transfusion-Dependent Thalassemia

Journal of clinical medicine, 2024-02, Vol.13 (5), p.1281

2024

Link zum Volltext

Verfügbarkeit prüfen

Multiparametric Cardiac Magnetic Resonance Assessment in Sickle Beta Thalassemia

Diagnostics (Basel), 2024-04, Vol.14 (7), p.691

2024

Link zum Volltext

Verfügbarkeit prüfen

Pancreatic T2 Magnetic Resonance Imaging for Prediction of Cardiac Arrhythmias in Transfusion-Dependent Thalassemia

Journal of clinical medicine, 2023-09, Vol.12 (18), p.6015

2023

Link zum Volltext

Verfügbarkeit prüfen

Severe iron overload in Blackfan‐Diamond anemia: A case‐control study

American journal of hematology, 2009-11, Vol.84 (11), p.729-732

2009

Link zum Volltext

Verfügbarkeit prüfen

Selecting β‐thalassemia Patients for Gene Therapy: A Decision‐making Algorithm

HemaSphere, 2021-05, Vol.5 (5), p.e555-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

New mutations inactivating transferrin receptor 2 in hemochromatosis type 3

Blood, 2001-05, Vol.97 (9), p.2555-2560

2001

Link zum Volltext

Verfügbarkeit prüfen

Liver stiffness assessed by transient elastography in patients with β thalassaemia major

Annals of hepatology, 2016-05, Vol.15 (3), p.410-417

2016

Link zum Volltext

Verfügbarkeit prüfen

Luspatercept: A New Kid on the Block

Hemoglobin, 2019-11, Vol.43 (6), p.328-328

2019

Link zum Volltext

Verfügbarkeit prüfen

IFNL3 polymorphisms and HCV infection in patients with beta thalassemia

Annals of hepatology, 2015-05, Vol.14 (3), p.389-395

2015

Link zum Volltext

Verfügbarkeit prüfen

Worsening of myocardial performance index in beta-thalassemia patients despite permanently normal iron load at MRI: A simple and cheap index reflecting cardiovascular involvement?

IJC metabolic & endocrine, 2016-12, Vol.13, p.41-44

2016

Link zum Volltext

Verfügbarkeit prüfen

Luspatercept improves hemoglobin levels and blood transfusion requirements in a study of patients with β-thalassemia

Blood, 2019-03, Vol.133 (12), p.1279-1289

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 133

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(124)
Mit Volltextzugriff
(126)

Publikationsform

Artikel
(129)
Berichte
(3)
Bücher
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Ineffective Erythropoiesis in β-Thalassaemia: Key Steps and Therapeutic Options by Drugs

Pharmacological and clinical evaluation of deferasirox formulations for treatment tailoring

Does Hepcidin Tuning Have a Role among Emerging Treatments for Thalassemia?

Epigenetic therapy for Friedreich ataxia

Bone densitometry in Thalassemia major: a closer look at pitfalls and operator-related errors in a 10-year follow-up population

Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver

Fontan circulation causes early, severe liver damage. Should we offer patients a tailored strategy?

Treating Thalassemia Patients with Luspatercept: An Expert Opinion Based on Current Evidence

Pregnancy and β-thalassemia: an Italian multicenter experience

Prevalence and prognostic impact of left ventricular non-compaction in patients with thalassemia

The effect of vitamin D pathway genes and deferasirox pharmacogenetics on liver iron in thalassaemia major patients

The Influence of Cardiovascular Risk Factors and Hypogonadism on Cardiac Outcomes in an Aging Population of Beta-Thalassemia Patients

Long-term safety and erythroid response with luspatercept treatment in patients with β-thalassemia

Non-Vitamin K Antagonist Oral Anticoagulants in Patients with β-Thalassemia

Prognostic Role of Multiparametric Cardiac Magnetic Resonance in Neo Transfusion-Dependent Thalassemia

Multiparametric Cardiac Magnetic Resonance Assessment in Sickle Beta Thalassemia

Pancreatic T2 Magnetic Resonance Imaging for Prediction of Cardiac Arrhythmias in Transfusion-Dependent Thalassemia

Severe iron overload in Blackfan‐Diamond anemia: A case‐control study

Selecting β‐thalassemia Patients for Gene Therapy: A Decision‐making Algorithm

New mutations inactivating transferrin receptor 2 in hemochromatosis type 3

Liver stiffness assessed by transient elastography in patients with β thalassaemia major

Luspatercept: A New Kid on the Block

IFNL3 polymorphisms and HCV infection in patients with beta thalassemia

Worsening of myocardial performance index in beta-thalassemia patients despite permanently normal iron load at MRI: A simple and cheap index reflecting cardiovascular involvement?

Luspatercept improves hemoglobin levels and blood transfusion requirements in a study of patients with β-thalassemia

Suchergebnisse filtern